Literature DB >> 9578893

Post-infection fatigue syndrome following Q fever.

J G Ayres1, N Flint, E G Smith, W S Tunnicliffe, T J Fletcher, K Hammond, D Ward, B P Marmion.   

Abstract

In 1989, 147 individuals in the West Midlands, UK, were infected with Q fever. Five years later, following anecdotal reports of fatigue, we used a questionnaire-based case-control study to determine the prevalence of chronic fatigue syndrome symptoms in this group. Replies from 71 patients were compared with those from 142 age- and sex-matched controls. Increased sweating (52.9% vs. 31.6%, p = 0.006), breathlessness (50.7% vs. 30.6%, p = 0.006), blurred vision (34.3% vs. 17.8%, p = 0.016) and undue tiredness (68.7% vs. 51.5%, p = 0.03) were found in controls compared to cases. These findings were similar to those in Australian abbatoir workers occupationally exposed to Q fever. CDC criteria for chronic fatigue syndrome were fulfilled by 42.3% of cases and 26% of controls. Using visual analogue scores, symptoms were more severe in cases than in controls. Our findings support the existence of a chronic fatigue state following acute Q fever, in a group of patients exposed just once to the organism, and in circumstances free of such confounding factors as lawsuits over compensation.

Entities:  

Mesh:

Year:  1998        PMID: 9578893     DOI: 10.1093/qjmed/91.2.105

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  34 in total

1.  Long term vascular complications of Coxiella burnetii infection. Cardiovascular risk factors cannot be ignored.

Authors:  M Wildman; J G Ayres
Journal:  BMJ       Date:  2000-01-01

2.  Seroprevalence to Coxiella burnetii among residents of the Hunter New England region of New South Wales, Australia.

Authors:  Aminul Islam; John Ferguson; Rod Givney; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 3.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.

Authors:  Ian Hickie; Tracey Davenport; Denis Wakefield; Ute Vollmer-Conna; Barbara Cameron; Suzanne D Vernon; William C Reeves; Andrew Lloyd
Journal:  BMJ       Date:  2006-09-01

Review 5.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 6.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Enterovirus related metabolic myopathy: a postviral fatigue syndrome.

Authors:  R J M Lane; B A Soteriou; H Zhang; L C Archard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

8.  Gene profiling of patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

9.  Pediatric Q Fever.

Authors:  Cara C Cherry; Gilbert J Kersh
Journal:  Curr Infect Dis Rep       Date:  2020-03-18       Impact factor: 3.725

10.  Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date.

Authors:  Joris Af van Loenhout; W John Paget; Jan H Vercoulen; Clementine J Wijkmans; Jeannine L A Hautvast; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.